BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.47% |
| NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | Specialty Chemicals | 2.73% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.67% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.55% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.35% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.24% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.20% |
| DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 2.10% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 2.09% |
| RGNX | Regenxbio Inc | Healthcare | Biotechnology | 1.91% |
| SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 1.85% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.83% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 1.75% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.70% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 1.69% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 1.69% |
| EDIT | Editas Medicine Inc | Healthcare | Biotechnology | 1.68% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 1.67% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.60% |